WELL Health Technologies Corp. (WELL.TO)
- Previous Close
3.9100 - Open
3.9100 - Bid 3.8400 x --
- Ask 3.8500 x --
- Day's Range
3.8200 - 3.9100 - 52 Week Range
3.6300 - 7.3600 - Volume
581,762 - Avg. Volume
1,000,508 - Market Cap (intraday)
976.217M - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
29.69 - EPS (TTM)
0.1300 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.65
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, and primary care. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR, Juno, and Profile (Intrahealth) and Cerebrum (AwareMD) EMR systems. The company was founded in 2010 and is headquartered in Vancouver, Canada.
well.company--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WELL.TO
View MorePerformance Overview: WELL.TO
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WELL.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WELL.TO
View MoreValuation Measures
Market Cap
976.22M
Enterprise Value
1.27B
Trailing P/E
29.69
Forward P/E
10.29
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.07
Price/Book (mrq)
1.13
Enterprise Value/Revenue
1.38
Enterprise Value/EBITDA
10.87
Financial Highlights
Profitability and Income Statement
Profit Margin
3.55%
Return on Assets (ttm)
-0.40%
Return on Equity (ttm)
3.28%
Revenue (ttm)
919.69M
Net Income Avi to Common (ttm)
32.61M
Diluted EPS (ttm)
0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
131.67M
Total Debt/Equity (mrq)
50.89%
Levered Free Cash Flow (ttm)
212.42M